Arctic Bioscience

Executive Summary

Arctic Bioscience is a Norwegian biotechnology company specializing in the development and manufacturing of premium bioactive ingredients derived from herring roe. Founded in 2017 and headquartered in Oslo, the company operates at the intersection of metabolic health and nutrition, leveraging marine resources to create innovative products with potential applications in dietary supplements, functional foods, and medical nutrition. While still private and pre-revenue based on available data, Arctic Bioscience has carved a niche in the growing market for omega-3 phospholipids, phospholipid-bound DHA and EPA, and other bioactive compounds found in herring roe. The company's value proposition lies in its sustainable sourcing from North Atlantic herring and its proprietary extraction processes that preserve the bioactivity of these compounds. Despite limited public information on clinical pipelines or commercial traction, Arctic Bioscience's focus on a unique, underutilized marine resource positions it as a potential player in the preventive health and personalized nutrition space, subject to validation through future partnerships or regulatory milestones.

Upcoming Catalysts (preview)

• Q4 2026First commercial product launch (e.g., dietary supplement or functional ingredient)60% success
• H1 2027Strategic partnership with a large nutraceutical or pharmaceutical company40% success
• Q2 2027Publication of clinical study results supporting health benefits50% success